Journal
FRONTIERS IN CARDIOVASCULAR MEDICINE
Volume 10, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fcvm.2023.1056663
Keywords
pediatric; heart failure; ventricular assist device; valvular heart disease; valve surgery (or cardiac surgery)
Categories
Ask authors/readers for more resources
Ventricular assist devices have significantly reduced mortality in children with end-stage heart failure awaiting transplant. Valve abnormalities, such as regurgitation, can impact the efficacy of hemodynamic support provided by these devices, so clinicians should carefully assess and repair any valve abnormalities in order to effectively support this diverse population.
Ventricular assist devices have become a valuable tool in the treatment of heart failure in children. The use of ventricular assist devices has decreased mortality in children with end-stage heart failure awaiting transplant. It is not uncommon for children with end-stage heart failure associated with cardiomyopathy or congenital heart disease to have significant systemic semilunar and atrioventricular valve regurgitation, which can impact the efficiency and efficacy of hemodynamic support provided by a ventricular assist device. Therefore, implanting clinicians should carefully assess for valve abnormalities that may need repair and impact device selection and cannulation strategy to effectively support this diverse population. The purpose of this review is to provide an overview of this important and relevant topic and to discuss strategies for managing these patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available